60
Participants
Start Date
November 12, 2013
Primary Completion Date
October 2, 2023
Study Completion Date
October 2, 2023
Natalizumab
As described in the treatment arm.
Research Site, Amadora
Research Site, Angra do Heroísmo
Research Site, Aveiro
Research Site, Braga
Research Site, Coimbra
Research Site, Faro
Research Site, Funchal
Research Site, Guimarães
Research Site, Leiria
Research Site, Lisbon
Research Site, Loures
Research Site, Matosinhos Municipality
Research Site, Penafiel
Research Site, Porto
Research Site, Santa Maria da Feira
Research Site, Setúbal
Research Site, Viana do Castelo
Research Site, Vila Nova de Gaia
Lead Sponsor
Biogen
INDUSTRY